For several years, Texas Health Presbyterian Hospital Dallas has been recognized by the American Heart Association for its successful, collaborative approach to treating acute coronary syndromes.
As a result, the AHA recently selected Texas Health Dallas for a unique site visit by delegates from the Chinese Society of Cardiology. Specifically, the delegates visited the local hospital to learn about ways to enhance care for something called STEMI, or ST-segment elevation myocardial infarction.
STEMI is caused by a complete blockage of blood flow to the heart. To prevent loss of life, the obstruction requires time-sensitive treatment to immediately restore blood flow, either by surgically opening the blocked vessel or by giving clot-busting medication.
Comprised of nine medical directors and professors of medicine, the Chinese delegates toured Texas Health Dallas’ emergency department, cardiac catheretization lab, and the ICU. They also met with several key members of the Texas Health Dallas leadership team, including Jim Berg, the hospital president, and Dr. James Park, interventional cardiologist on the Texas Health Dallas medical staff.